PEAK6 Investments’s Core Laboratories CLB Stock Holding History

PEAK6 Investments’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,900	Closed	-$277K	–	4103
2023 Q2	$277K	Buy	+11,900	New	+$269K	﹤0.01%	2661
2022 Q3	–	Sell	-19,600	Closed	-$430K	–	5090
2022 Q2	$430K	Sell	19,600 -47,900	-71%	-$1.27M	﹤0.01%	3976
2022 Q1	$2.13M	Buy	+67,500	New	+$1.89M	﹤0.01%	1789
2021 Q3	–	Sell	-7,000	Closed	-$273K	–	5234
2021 Q2	$273K	Buy	7,000 +5,300	+312%	+$190K	﹤0.01%	3760
2021 Q1	$49K	Buy	+1,700	New	+$58.1K	﹤0.01%	4496
2020 Q4	–	Sell	-10,000	Closed	-$153K	–	4622
2020 Q3	$153K	Sell	10,000 -24,600	-71%	-$516K	﹤0.01%	3652
2020 Q2	$703K	Buy	34,600 +9,600	+38%	+$172K	﹤0.01%	2405
2020 Q1	$258K	Sell	25,000 -17,300	-41%	-$484K	﹤0.01%	2631
2019 Q4	$1.59M	Buy	42,300 +38,200	+932%	+$1.72M	0.01%	1250
2019 Q3	$189K	Buy	+4,100	New	+$191K	﹤0.01%	2920
2019 Q2	–	Sell	-22,900	Closed	-$1.58M	–	3729
2019 Q1	$1.58M	Buy	+22,900	New	+$1.54M	0.01%	1468
2018 Q4	–	Sell	-11,000	Closed	-$1.27M	–	4080
2018 Q3	$1.27M	Buy	+11,000	New	+$1.24M	0.01%	1800

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PEAK6 Investments's CLB Position: Q3 2024 in Review

PEAK6 Investments reduced its Core Laboratories (CLB) stake by 66% in Q3 2024, selling an estimated $801K and leaving 20,750 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #2467.

PEAK6 Investments first reported a position in CLB in Q3 2018 and has held it in 18 quarters since. The position peaked at $4.87M in Q3 2019. 191 funds tracked by Wall St. Rank hold CLB as of Q3 2024.

PEAK6 Investments held 20,750 shares of Core Laboratories worth $384K as of Q3 2024.
PEAK6 Investments sold 39,910 Core Laboratories shares in Q3 2024, an estimated $801K.
Core Laboratories made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2467 holding.
PEAK6 Investments first reported a position in Core Laboratories in Q3 2018 and has held it in 18 quarters since.
PEAK6 Investments's Core Laboratories position peaked at $4.87M in Q3 2019.
191 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.